Bacterial and Viral Coinfections with the Human Respiratory Syncytial Virus

Gaspar A Pacheco1, Nicolás M S Gálvez1, Jorge A Soto1

  • 1Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Millennium Institute of Immunology and Immunotherapy, Pontificia Universidad Católica de Chile, Santiago 8320000, Chile.

Microorganisms
|July 2, 2021
PubMed

Insights

Human respiratory syncytial virus (hRSV) causes severe respiratory infections in young children. This review explores common polymicrobial infections involving hRSV and other pathogens, highlighting the need for research into their interactions.

Area of Science:

  • Pediatric infectious diseases
  • Virology
  • Microbiology

Background:

  • Human respiratory syncytial virus (hRSV) is a major cause of lower respiratory tract infections in children under five.
  • hRSV infections can lead to pneumonia and long-term respiratory issues like asthma.
  • No vaccines are currently approved for hRSV prevention, despite significant disease burden.

Purpose of the Study:

  • To review the epidemiology and recent findings on polymicrobial infections involving hRSV.
  • To identify common bacterial and viral co-pathogens frequently found with hRSV.
  • To emphasize the lack of molecular understanding of these interactions and stimulate research.

Main Methods:

  • Literature review of epidemiological data and recent research findings.
  • Identification and compilation of prevalent bacterial and viral pathogens associated with hRSV infections.
  • Analysis of existing knowledge on pathogen interactions in polymicrobial respiratory diseases.

Main Results:

  • hRSV frequently co-infects with various bacteria (e.g., Staphylococcus aureus, Streptococcus pneumoniae) and viruses (e.g., influenza A, human rhinoviruses).
  • Polymicrobial infections are particularly common when hRSV illness progresses to pneumonia.
  • Current understanding of the molecular mechanisms underlying these co-infections is limited.

Conclusions:

  • Polymicrobial infections involving hRSV are common and contribute to disease severity.
  • Further research is critically needed to elucidate the molecular interactions between hRSV and other respiratory pathogens.
  • Understanding these interactions may pave the way for novel therapeutic and preventative strategies.

Related Concept Videos

Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
24.1K
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.0K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.6K
Upper Respiratory Drugs: Decongestants01:27

Upper Respiratory Drugs: Decongestants

Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion.
Most decongestants are readily available over-the-counter in...
491
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
1.3K
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
437